台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效

生華科

(6492)
可現股當沖
  • 股價
    41.30
  • 漲跌
    ▲0.60
  • 漲幅
    +1.47%
  • 成交量
    122
  • 產業
    上櫃 生技醫療類股
  • 147人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
生華科 (6492)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/03/27     後一日»

券商獲利排行 - 2024/03/27

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  5.21%20.5020.5-90943.6043.641.3
  5.49%19.2019.2-80843.7043.741.3
  5.36%18.7018.7-80843.6043.641.3
  4.67%16.2016.2-80843.3043.341.3
  4.81%10.50.79.8-41543.643.143.841.3
  4.73%10.3010.3-50543.4043.441.3
  4.62%10010-50543.3043.341.3
  5.78%7.607.6-30343.8043.841.3
  4.10%7.10.46.8-31443.543.243.641.3
  4.09%7.107.1-40443.1043.141.3
  4.80%6.306.3-20343.443.843.441.3
  4.40%5.705.7-30343.2043.241.3
  5.11%4.504.5-20243.5043.541.3
  4.62%404-20243.3043.341.3
  4.56%404-10243.343.843.341.3
  3.95%3.403.4-2024304341.3
  3.95%3.403.4-2024304341.3
  5.82%2.602.6-10143.9043.941.3
  5.82%2.602.6-10143.9043.941.3
  5.82%2.602.6-10143.9043.941.3
  5.82%2.602.6-10143.9043.941.3
  5.71%2.502.5-10143.8043.841.3
  5.60%2.502.5-10143.8043.841.3
  5.49%2.402.4-10143.7043.741.3
  5.49%2.402.4-10143.7043.741.3
  5.50%2.402.400143.743.543.741.3
  5.27%2.302.300143.643.743.641.3
  5.17%2.302.3-10143.6043.641.3
  5.06%2.202.2-10143.5043.541.3
  4.95%2.202.2-10143.5043.541.3
  4.73%2.102.1-10143.4043.441.3
  4.62%202-10143.3043.341.3
  4.62%202-10143.3043.341.3
  4.51%202-10143.3043.341.3
  1.96%0.90.9001143.44343.941.3
  1.49%0.60.6001143.643.343.941.3
  0.14%0.6-1.62.108943.543.643.441.3
  1.15%0.50.5001143.743.443.941.3
  1.15%0.50.5001143.643.343.841.3
  0.98%0.40.4001143.443.243.641.3
   00000043.843.8041.3
   00000043.943.9041.3
   00000043.843.8041.3
   00000043.643.6041.3
   00000043.943.9041.3
   00000043.843.8041.3
   00000043.943.9041.3
   00000043.843.8041.3
   00000044.344.3041.3
   00000043.843.8041.3

券商虧損排行 - 2024/03/27

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -5.40%-37.70-37.71616043.743.7041.3
  -5.67%-19.90-19.988043.843.8041.3
  -4.62%-160-1688043.343.3041.3
  -4.76%-14.50-14.577043.443.4041.3
  -5.49%-120-1255043.743.7041.3
  -3.29%-11.51-12.468243.543.443.941.3
  -3.11%-10.8-1.6-9.248443.543.643.241.3
  -4.51%-7.80-7.844043.343.3041.3
  -5.92%-5.20-5.222043.943.9041.3
  -5.92%-5.20-5.222043.943.9041.3
  -4.03%-5.20-5.23304343041.3
  -4.73%-4.10-4.122043.443.4041.3
  -3.96%-3.40-3.42204343041.3
  -5.92%-2.60-2.611043.943.9041.3
  -5.82%-2.60-2.611043.943.9041.3
  -5.49%-2.40-2.411043.743.7041.3
  -5.28%-2.30-2.311043.643.6041.3
  -5.28%-2.30-2.311043.643.6041.3
  -5.17%-2.30-2.311043.643.6041.3
  -5.17%-2.30-2.311043.643.6041.3
  -5.06%-2.20-2.211043.543.5041.3
  -5.06%-2.20-2.211043.543.5041.3
  -5.06%-2.20-2.211043.543.5041.3
  -5.06%-2.20-2.211043.543.5041.3
  -4.95%-2.20-2.211043.543.5041.3
  -4.73%-2.10-2.111043.443.4041.3
  -4.62%-20-211043.343.3041.3
  -4.40%-1.90-1.911043.243.2041.3
  -4.40%-1.90-1.911043.243.2041.3
  -3.95%-1.70-1.71104343041.3
  -3.95%-1.70-1.71104343041.3
  -1.55%-1.40.6-212143.543.343.941.3
  -0.41%-1.30.9-2.207643.543.543.641.3
  -0.75%-0.7-0.7002243.543.743.441.3
  -0.80%-0.4-0.4001143.743.943.541.3
  -0.69%-0.3-0.3001143.543.643.341.3
  -0.69%-0.3-0.3001143.743.943.641.3
  -0.23%-0.1-0.1001143.443.443.341.3
   00000043.543.5041.3
   00000044.3044.341.3
   00000043.843.8041.3
   00000043.643.6041.3
   00000043.543.5041.3
   00000043.543.5041.3
   00000043.843.8041.3
   00000044.344.3041.3
   00000043.643.6041.3
   00000043.543.5041.3
   00000043.543.543.441.3
   00000043.443.4041.3
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-13天前
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科泛病毒感染肺炎新藥 向美申請二期臨床Anue鉅亨-2023/10/19
生華科 相關文章
生華科 相關影音